Alternatively, the interference with the chromatin kinase VRK1 (Campillo-Marcos and Lazo, 2019; Campillo-Marcos et al., 2021), could be a novel alternative strategy of synthetic lethality in glioblastomas. This evidence concerns the gene VRK1 and glioblastoma.